CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Co. v. Merck & Co., Inc.

1:15-cv-00560

📡 5G SEP • ETSI Declared

Overview

Case Number 1:15-cv-00560
Filing Date 2015-06-30
Status Terminated
Termination Date 2017-01-23
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Bristol-Myers Squibb Co. Operating Company

Represented By

12 Attorneys Listed

Rachel J. Elsby

Email: relsby@akingump.com

Jason E. Weil

Email: jweil@akingump.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Angela Verrecchio

Email: averrecchio@akingump.com

Dianne B. Elderkin

Email: delderkin@akingump.com

Jenna M. Pellecchia

Email: jpellecchia@akingump.com

Steven D. Maslowski

Email: smaslowski@akingump.com

Emily C. Johnson

UNDELIVERABLE EMAIL 8/22/2016

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Melissa R. Gibson

Email: mgibson@akingump.com

Matthew Alan Pearson

Akin Gump Strauss Hauer & Feld LLP

Tel: +1 (215) 965-1200

1735 Market Street, Ste 12th Floor

Merck Sharp & Dohme Corp. Operating Company

Represented By

4 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Merck & Co., Inc. Operating Company

Represented By

17 Attorneys Listed

Lauren Cranford Katzeff

Email: lkatzeff@sidley.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Kirsten E. Braun

Email: kbraun@sidley.com

Lisa A. Schneider

Email: lschneider@sidley.com

David T. Pritikin

Email: dpritikin@sidley.com

Jeffrey P. Kushan

Email: jkushan@sidley.com

Michael D. Hatcher

Email: mhatcher@sidley.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

William H. Baumgartner , Jr.

Email: wbaumgar@sidley.com

Fitz B. Collings

Email: fcollings@sidley.com

Grace I. Chiang

Email: gchiang@sidley.com

Leif E. Peterson , II

Email: leif.peterson@sidley.com

Todd L. Krause

Email: tkrause@desmaraisllp.com

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Gwen Stewart

Email: gstewart@sidley.com

Steven J. Horowitz

Email: shorowitz@sidley.com

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

Dana-Farber Cancer Institute, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Tasuku Honjo NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Matthew Alan Pearson

Akin Gump Strauss Hauer & Feld LLP

Tel: +1 (215) 965-1200

1735 Market Street, Ste 12th Floor

E.R. Squibb & Sons L.L.C. Operating Company

Represented By

4 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Matthew Alan Pearson

Akin Gump Strauss Hauer & Feld LLP

Tel: +1 (215) 965-1200

1735 Market Street, Ste 12th Floor

Ono Pharmaceutical Co., Ltd Operating Company

Represented By

4 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Matthew Alan Pearson

Akin Gump Strauss Hauer & Feld LLP

Tel: +1 (215) 965-1200

1735 Market Street, Ste 12th Floor

Respondent

Dr. Clive Wood NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2016-06-30
IPR2016-01219

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

U.S. Continuation Sibling (9073994)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01221

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

U.S. Continuation Sibling (9073994)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01218

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01217

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP • ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

✓ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
✓ Right to demand global FRAND portfolio determination.
✓ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9067999
Immunopotentiative composition
Filed: 2015-03-04
Issued: 2015-06-30
Active (8.3 yrs remaining)
Expires: 2035-03-04
US8728474
Immunopotentiative composition
Filed: 2010-12-02
Issued: 2014-05-20
Expired (Term Ended)
Expires: 2025-10-02
US9073994
Immunopotentiative composition
Filed: 2014-11-21
Issued: 2015-07-07
Active (8.0 yrs remaining)
Expires: 2034-11-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

39

Dispositive

14

Granted

0

Denied

0

Pending / Review

23

Motions by Category

Procedural / Extension Motion 9 Motion to Dismiss (FRCP 12(b)(6)) 10 Motion to Dismiss 1 Claim Construction / Markman Filing 16 Motion to Transfer Venue (28 U.S.C. § 1404) 1 Motion for Summary Judgment (Rule 56) 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
Letter to The Honorable Gregory M. Sleet from Daniel M. Silver regarding Reply in Support of Defendants' Request for Permission to File a Motion for Summary Jud...
Entry #204 • 2016-10-28 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Letter to The Honorable Gregory M. Sleet from Michael P. Kelly, Esq. regarding Defendants' Request for Leave to File a Motion for Summary Judgment. (Kelly, Mich...
Entry #198 • 2016-10-07 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
MEMORANDUM OPINION re Motion to Transfer. Signed by Judge Gregory M. Sleet on 7/13/2016. Associated Cases: 1:14-cv-01131-GMS, 1:15-cv-00560-GMS, 1:15-cv-00572-G...
Entry #172 • 2016-07-13 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ORDER - denying defendants' Motion to Dismiss for Failure to State a Claim ( 5 ). Signed by Judge Gregory M. Sleet on 3/17/2016. (mdb)
Entry #70 • 2016-03-17 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY BRIEF re 5 MOTION to Dismiss for Failure to State a Claim filed by Merck & Co., Inc., Merck Sharp & Dohme Corp.. (Mayo, Andrew) (Entered: 10/14/2015)
Entry #16 • 2015-10-14 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending
ANSWERING BRIEF in Opposition re 5 MOTION to Dismiss for Failure to State a Claim filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Ono Pharmaceutic...
Entry #15 • 2015-09-25 Document →

Docket Entries

(340 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against All Defendants - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1747685.) - filed by Bristol-Myers Squibb Co., Tasuku Honjo, Ono Pharmaceutical Co., Ltd, E.R. Squibb & Sons L.L.C.. (Attachments: # 1 Exhibit, # 2 Civil Cover Sheet)(aah) (Entered: 06/30/2015)

Entry #1 • 2015-06-30
1
Pleading / Complaint

COMPLAINT filed with Jury Demand against All Defendants - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1747685.) - filed by Bristol-Myers Squibb Co., Tasuku Honjo, Ono Pharmaceutical Co., Ltd, E.R. Squibb & Sons L.L.C.. (Attachments: # 1 Exhibit, # 2 Civil Cover Sheet)(aah) (Entered: 06/30/2015)

Entry #1 • 2015-06-30
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against All Defendants - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1747685.) - filed by Bristol-Myers Squibb Co., Tasuku Honjo, Ono Pharmaceutical Co., Ltd, E.R. Squibb & Sons L.L.C.. (Attachments: # 1 Exhibit, # 2 Civil Cover Sheet)(aah) (Entered: 06/30/2015)

Entry #1 • 2015-06-30
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 06/30/2015)

Entry #2 • 2015-06-30
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,067,999 B1; (aah) (Entered: 06/30/2015)

Entry #3 • 2015-06-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc